Literature DB >> 4112010

The nitroblue tetrazolium reaction in human granulocytes adherent to a surface.

R H Gifford, S E Malawista.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4112010      PMCID: PMC2591855     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  14 in total

1.  A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females.

Authors:  D B Windhorst; B Holmes; R A Good
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

2.  Quantitative nitroblue tetrazolium test in chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan
Journal:  N Engl J Med       Date:  1968-05-02       Impact factor: 91.245

3.  A simple rapid micromethod for detecting chronic granulomatous disease of childhood.

Authors:  R H Gifford; S E Malawista
Journal:  J Lab Clin Med       Date:  1970-03

4.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

5.  Increased reduction of nitrobule tetrazolium by neutrophils of newborn infants.

Authors:  J R Humbert; M L Kurtz; W E Hathaway
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

6.  Decreased nitroblue tetrazolium dye reduction in the phagocytes of patients receiving prednisone.

Authors:  D R Miller; H G Kaplan
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

7.  Leukocyte oxidase: defective activity in chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan
Journal:  Science       Date:  1967-02-17       Impact factor: 47.728

8.  Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease.

Authors:  D G Nathan; R L Baehner; D K Weaver
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

9.  Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants.

Authors:  B H Park; B M Holmes; G E Rodey; R A Good
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  7 in total

1.  Cytokineplasts from human blood polymorphonuclear leukocytes. Lack of oxidase activity and extended functional longevity.

Authors:  S E Malawista; G Van Blaricom; S B Cretella
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

2.  Ingestion of Giardia lamblia trophozoites by murine Peyer's patch macrophages.

Authors:  D R Hill; R Pohl
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  Impaired bacteriological responses in babies after maternal iron dextran infusion.

Authors:  M H Webster; S A Waitkins; A Stott
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

4.  Antimicrobial, immunological and biochemical effects of florfenicol and garlic (Allium sativum) on rabbits infected with Escherichia coli serotype O55: H7.

Authors:  Verginia M Farag; Reham A El-Shafei; Rasha M Elkenany; Hanaa S Ali; Abdelfattah H Eladl
Journal:  Vet Res Commun       Date:  2021-11-10       Impact factor: 2.459

5.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.

Authors:  P M Henson; Z G Oades
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

7.  Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease.

Authors:  R J Levinsky; B A Harvey; C H Rodeck; J F Soothill
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.